Literature DB >> 31961100

Genistein Represses HOTAIR/Chromatin Remodeling Pathways to Suppress Kidney Cancer.

Mitsuho Imai-Sumida1, Pritha Dasgupta1, Priyanka Kulkarni1, Marisa Shiina1, Yutaka Hashimoto1, Varahram Shahryari1, Shahana Majid1, Yuichiro Tanaka1, Rajvir Dahiya1, Soichiro Yamamura2.   

Abstract

BACKGROUND/AIMS: Genistein, a soy isoflavone, has been shown to have anti-cancer effects in various cancers including renal cancer. Long non-coding RNA, HOX transcript antisense RNA (HOTAIR), is involved in cancer progression and metastasis, such as renal cancer. Our aim was to investigate the effects of genistein on HOTAIR chromatin remodeling functions.
METHODS: We used MTS assays and Transwell migration assays to study the effects of genistein on cell proliferation and migration respectively in human renal cell carcinoma (RCC) cell lines. We used Western blots to analyze SNAIL and ZO-1 expression. We performed chromatin immunoprecipitation (ChIP) assays to study recruitment of the polycomb repressive complex 2 (PRC2) to the ZO-1 promoter. We performed RNA immunoprecipitation (RIP) assays to study interaction between HOTAIR and PRC2, SMARCB1 or ARID1A. We also performed transfection experiments to overexpress EED, HOTAIR and knockdown SMARCB1.
RESULTS: Genistein reduced cell proliferation and migration of human renal cell carcinoma cell lines. ChIP assays indicated that genistein reduces recruitment of the PRC2 to the ZO-1 promoter and increased its expression. RIP assays showed that genistein inhibits HOTAIR interaction with PRC2, leading to tumor suppression. Immunoprecipitation also revealed that genistein reduced EED levels in PRC2, suggesting that decreased EED levels suppress HOTAIR interaction with PRC2. EED overexpression in the presence of genistein restored PRC2 interaction with HOTAIR and reduced ZO-1 transcription, suggesting genistein activates ZO-1 by inhibiting HOTAIR/PRC2 functions. RIP assays also showed that HOTAIR interacts with SMARCB1 and ARID1A, subunits of the human SWI/SNF chromatin remodeling complex and genistein reduces this interaction. Combination of HOTAIR overexpression and SMARCB1 knockdown in the presence of genistein revealed that genistein inhibits SNAIL transcription via the HOTAIR/SMARCB1 pathway.
CONCLUSION: Genistein suppresses EED levels in PRC2 and inhibits HOTAIR/PRC2 interaction. Genistein suppresses HOTAIR/PRC2 recruitment to the ZO-1 promoter and enhances ZO-1 transcription. Genistein also inhibits SNAIL transcription via reducing HOTAIR/SMARCB1 interaction. We demonstrate that the reduction of HOTAIR interaction with chromatin remodeling factors by genistein represses HOTAIR/chromatin remodeling pathways to suppress RCC malignancy. © Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Entities:  

Keywords:  Genistein; HOTAIR; PRC2; Renal cancer; SMARCB1

Mesh:

Substances:

Year:  2020        PMID: 31961100      PMCID: PMC7382546          DOI: 10.33594/000000205

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  50 in total

Review 1.  Flavonoids as prospective compounds for anti-cancer therapy.

Authors:  Divyashree Ravishankar; Amit Kumar Rajora; Francesca Greco; Helen M I Osborn
Journal:  Int J Biochem Cell Biol       Date:  2013-10-12       Impact factor: 5.085

Review 2.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

3.  SWI/SNF chromatin-remodeling complexes function in noncoding RNA-dependent assembly of nuclear bodies.

Authors:  Tetsuya Kawaguchi; Akie Tanigawa; Takao Naganuma; Yasuyuki Ohkawa; Sylvie Souquere; Gerard Pierron; Tetsuro Hirose
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 4.  Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?

Authors:  Olivier Rouvière; Raymonde Bouvier; Sylvie Négrier; Lionel Badet; Denis Lyonnet
Journal:  Nat Clin Pract Oncol       Date:  2006-04

Review 5.  The SWI/SNF complex and cancer.

Authors:  D Reisman; S Glaros; E A Thompson
Journal:  Oncogene       Date:  2009-02-23       Impact factor: 9.867

Review 6.  The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer.

Authors:  Courtney Hodges; Jacob G Kirkland; Gerald R Crabtree
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

Review 7.  HOTAIR: an oncogenic long non-coding RNA in different cancers.

Authors:  Mohammadreza Hajjari; Abbas Salavaty
Journal:  Cancer Biol Med       Date:  2015-03       Impact factor: 4.248

8.  Promiscuous RNA binding by Polycomb repressive complex 2.

Authors:  Chen Davidovich; Leon Zheng; Karen J Goodrich; Thomas R Cech
Journal:  Nat Struct Mol Biol       Date:  2013-09-29       Impact factor: 15.369

9.  Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma.

Authors:  Wei Jiang; Essel Dulaimi; Karthik Devarajan; Theodore Parsons; Qiong Wang; Raymond O'Neill; Charalambos Solomides; Stephen C Peiper; Joseph R Testa; Robert Uzzo; Haifeng Yang
Journal:  Oncotarget       Date:  2017-06-06

10.  omiXcore: a web server for prediction of protein interactions with large RNA.

Authors:  Alexandros Armaos; Davide Cirillo; Gian Gaetano Tartaglia
Journal:  Bioinformatics       Date:  2017-10-01       Impact factor: 6.937

View more
  7 in total

Review 1.  Long non-coding RNAs: the tentacles of chromatin remodeler complexes.

Authors:  Audrey Vincent; Isabelle Van Seuningen; Bernadette Neve; Nicolas Jonckheere
Journal:  Cell Mol Life Sci       Date:  2020-10-01       Impact factor: 9.261

Review 2.  A putative role for lncRNAs in epigenetic regulation of memory.

Authors:  Ashleigh B Irwin; Rudhab Bahabry; Farah D Lubin
Journal:  Neurochem Int       Date:  2021-09-14       Impact factor: 3.921

Review 3.  Dietary Phytoestrogens and Their Metabolites as Epigenetic Modulators with Impact on Human Health.

Authors:  Victor Stefan Ionescu; Alexandra Popa; Andrei Alexandru; Emilia Manole; Mihaela Neagu; Sevinci Pop
Journal:  Antioxidants (Basel)       Date:  2021-11-26

Review 4.  The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research.

Authors:  Na Song; Kai Cui; Ke Zhang; Jie Yang; Jia Liu; Zhuang Miao; Feiyue Zhao; Hongjing Meng; Lu Chen; Chong Chen; Yushan Li; Minglong Shao; Jinghang Zhang; Haijun Wang
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

Review 5.  The protective activity of genistein against bone and cartilage diseases.

Authors:  Zhenyu Wu; Luying Liu
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

6.  Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cells.

Authors:  Liujia Chan; Yuheng Pang; Yuji Wang; Di Zhu; Ayijinag Taledaohan; Yijiang Jia; Lichun Zhao; Wenjing Wang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

7.  Long noncoding RNA ENST00000508435 promotes migration of breast cancer via FXR 1.

Authors:  Luying Li; Youping Jin; Xue Wang; Li Wang; Yangbai Sun; Yihong Luo; Xiaojian Ni; Qi Lu; Wenbo Wei; Xiuling Zhi; Jerry Yu; Wei Zhu; Ping Zhou
Journal:  Cell Adh Migr       Date:  2021-12       Impact factor: 3.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.